Customer Stories
We are living in an age of rapid scientific discovery, generating ever more detailed insights into the building blocks of life – DNA, RNA and proteins. These advances are improving our everyday lives, changing the way people are treated for illnesses like cancer, tuberculosis and genetic disease, helping to find new medicines and even safeguarding the public. Our customers are the heroes stepping up to the challenge of unlocking answers and driving these discoveries. Explore a wide range of customer stories and videos on their scientific breakthroughs and healthcare advances below.
-
Syndromic testing | QIAstat-DxQuick pivot enables lab to serve community during pandemic
Great Lakes Labs president and CEO Michelle Volk redirected her lab’s focus from forensics to clinical medicine in reaction to the COVID-19 pandemic to provide her community with rapid, accurate testing, and peace of mind. -
Sample Technology I QIAsymphony & DNA kitsUsing bacterial signatures to screen for colorectal cancers
The team at GoodGut develop an uninstructive alternative to current colorectal cancer diagnostic methods (which can often result in complications) using gut bacteria. -
Diagnostics & Clinical Research | therascreenTreatments for patients on day one
NeoGenomics, the U.S.’s largest cancer diagnostic company set a precedent for the future of diagnostics by delivering a novel treatment to breast cancer patients on day one. -
Sample Prep | DNA ExtractionSaving biodiversity through DNA barcoding
Dr. Fontanilla guides conservation efforts to turn the tide on mass extinction and illegal wildlife trade using through DNA barcoding. -
dPCRIdentifying the genetics behind obesity using dPCR
Digital PCR technology determines exact copy numbers from a single gene explaining why some individuals are prone to obesity. -
Genomics | QIAseq NGS SolutionsFaster cancer diagnoses using Artificial Intelligence
Japanese startup, PFDeNA, uses deep learning to quickly and accurately detect and diagnose different cancer types. -
Microbiome | DNA KitsUsing the human microbiome to decipher crime scene traces
Forensic investigators analyze genomes of human microorganisms to determine what took place at a crime scene. -
Syndromic testing | QIAstat-DxAvoiding repeat hospital visits with syndromic testing
The team at Mako Medical ensure fast test results to vulnerable senior communities, knowing that delays can present a real dilemma for patients with little time for diagnoses. -
Infectious Disease | TuberculosisBattling tuberculosis in the time of COVID-19
Dr. Story brings tuberculosis testing and treatment to susceptible homeless communities knowing that a disruption in TB testing during COVID would have major consequences. -
PCR | Digital PCRdPCR. Standardized diagnostics from London to Shanghai.
Dr. Jim Huggett is using digital PCR to overcome one of the biggest challenges in diagnostics: how to standardize tests globally. -
Infectious Disease | COVID-19Ensuring critical deliveries when every minute countsUPS teams up with QIAGEN to deliver coronavirus testing solutions to curb the SARS-CoV-2 pandemic. -
TB Management l QuantiFERONTuberculosis diagnosis turns patients into advocates
A trip to Africa set a couples’ life on a course they will never forget after contracting the world’s deadliest infectious disease. -
Infectious Disease | COVID-19Achieving production goals in record time
Maine company pushes the limit and does the impossible to design a spin column machine in record time to help in testing for coronavirus. -
HID & Forensics | Investigator SolutionsDeciphering RNA to solve impossible crime scenes
Forensic scientists are finding answers to almost impossible human ID cases with degraded and challenges samples through the help of RNA. -
Microbiome | DNA KitsAir microbiome provides answers to climate change
London researcher sequences invisible microbiome in air to understand why and how this ecosystem evolves. -
About QIAGEN I Digital TransformationThe digital mindset is part of our DNA
A team in Poland is transforming QIAGEN in the age of digitization. -
Infectious Disease | COVID-19Suppliers behind the front lines of COVID-19Suppliers are finding novel solutions to help diagnostic companies like QIAGEN ramp up production to provide urgently needed COVID-19 testing materials. -
COVID-19Latest newsLatest news on QIAGEN efforts to support healthcare workers in controlling the coronavirus (COVID-19) outbreak – now a pandemic. -
BioinformaticsAnalyzing the ancient origins of rare genetic diseases
Pushing the limits of genetic research in the study of rare disease in Turkey. -
TB Management | QuantiFERONTesting millions to stop tuberculosis migration
Why labor migration is an important factor in fighting against the world's deadliest infectious disease. -
Sample Prep | RNeasy KitRecovering RNA from miniscule samples
Using QIAGEN’s RNeasy Kit to purify quality RNA from colonic biopsies gaining insights to combat inflammatory bowel disease (IBD). -
Microbiome | DNA kitsGut microbiomes as a cancer therapy
Specific bacteria within human microbiomes are utilized to lower side effects that come with oncological patient care. -
NGSThe immune system as medicine
Immune cells are manipulated to defend against cancer using QIAGEN’s next-generation sequencing technologies. -
HID & ForensicsExplosive discoveries from trace DNA
Extracting seemingly impossible information from highly degraded touch DNA left on explosives and firearms with QIAGEN’s DNA extraction kits. -
Bioinformatics | IPANeutralizing a bio-terrorist threat
Unraveling the mysterious pathways of a biodefense pathogen using IPA in the search for a therapeutic against dangerous arboviruses. -
GenomicsAttacking cancer from all angles
How QIAseq FastSelect helps pave the way towards more successful cancer treatment -
Infectious DiseaseA new frontier for PCR testing
The NeuMoDx 288 Molecular System is tested in one of the largest medical labs in Eastern Germany. -
GenomicsDiabetes linked to arsenic
Discovering the connection between environmental arsenic exposure and type II diabetes with QIAGEN Genomic Services. -
NGSOn the brink of a breakthrough
Solving the mystery of an extremely high incidence of lung cancer in Northern Thailand with QIAGEN´s GeneReader NGS System. -
TB ManagementMaking an impact in Africa
A task with a mission: helping the thousands of refugees and migrants dependent on fast and accurate latent TB results. -
TB ManagementFighting the unknown
How a mystery ailment rattled a teacher and hundreds of students in Vermont. -
Infectious DiseasesIs it Influenza – or something else?
A new syndromic testing device, the QIAstat-Dx is cutting costs and saving time in the emergency room. -
HID & ForensicsBringing closure to families
A new NGS workflow allows identification of missing persons from the most difficult samples. -
NGSA transforming profession
How the GeneReader NGS System is transforming a pathologist’s work. -
NGSA promising future
Interview with Dr. Richard K. Wilson, of the Children’s Hospital in Columbus, on the advances in genomic science. -
AUTOMATIONAutomating diagnostics for the future
Herlev hospital meets new demands in patient care by enhancing their workflow through automation. -
Cancer ResearchBreaking the code - companion diagnostics
The benefits of companion diagnostics become clear at the Queen Elizabeth Hospital in Birmingham, England. -
Infectious DiseasesBattling infectious diseases
Geneva-based non-profit FIND, combats widespread poverty-related diseases with collaborative approaches to defeat new epidemic threats. -
NGSInterview Prof. Paul Hofman
Interview with Professor Paul Hofman as he explains the challenges in pathology and new approaches in the field using NGS. -
NGSThe dawn of a new age
Professor Paul Hofman uses next-generation sequencing to gain unparalleled insights in oncology. -
MicrobiomeBehavior - it's all in our gut
Interview with Dr. Michael Montague on how the gut microbiome of free-ranging primates shapes their social interactions and vice versa. -
TuberculosisOur goal is to develop easy and quick tests
Interview with Dr. Delia Goletti in her fight against tuberculosis at Italy’s National Institute for Infectious Disease. -
TuberculosisFighting a common and persistent killer
The rise of multi-resistant strains of the most common chronic global infection demands new approaches in fighting the disease. -
MicrobiomeMapping a hidden world
Scientists around the world embark on an ambitious project to chart and better understand the microbiome on every surface. -
NGSSingapore showcase
Dr. Liu Jianjun plans on sequencing the genome of 10,000 Singaporeans in an effort to revolutionize medical science using Big Data. -
Life Science ResearchMans best friend
Dr. Tomas Bergström and his team are carrying out groundbreaking genetic research on dogs that has huge potential benefits for human health. -
AUTOMATIONDiverse appeal
Four experts in four countries. What do their laboratories have in common? The QIAsymphony system. -
TuberculosisLike a smoldering ember that can catch fire again
How the leading TB assay can help tackle Japan’s high infection rates and the world’s top infectious disease killer. -
HID & ForensicsLooking to the future of missing persons analysis with NGS
The International Commission on Missing Persons collaborates with QIAGEN in becoming the leader in human identity testing. -
CSR
Support and challenge
Integrating qualified refugees into the local labor market of western societies to strengthen our communities. -
Life Science ResearchCracking the code - how RNA may hold the answer
Geneticists try to unravel the mysteries of RNA as it plays a vital role in regulating normal physiology. -
HID & ForensicsNames for the dead certainty for the survivors
The largest-ever DNA identification project is underway to name those who perished more than 40 years ago in the Vietnam War. -
Cancer researchBetween two worlds
Interview with leading pathologist Dr. Soonmyung Paik discussing the development and use of genetic testing in cancer patient treatments. -
Infectious DiseasesBeating healthcare-associated infections
Controlling healthcare-associated infections with advanced molecular tests and preventive screening.